Trava explicitly states that their partner pharmacies compound products consistent with state and federal law and applicable safety and sterility standards set by the United States Pharmacopoeia
Because the published Phase 2 pharmacology characterizes it as having comparable potency at all three receptors rather than being a single-receptor compound with weak off-target activity
More significant results accumulate over three to nine months, depending on dosing, adherence, and individual physiology
Vision Loss (NAION) Documentation If you are filing for vision loss, your case relies on ophthalmology-specific imaging: OCT (Optical Coherence Tomography): Scans showing optic nerve head edema (swelling)
Severe Gastrointestinal Disease: Foundayo is associated with gastrointestinal side effects, such as nausea, diarrhea, vomiting, constipation, and stomach pain and they can sometimes be severe